Sterol metabolism/biosynthesis, phosphomevalonate kinase
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005777 | peroxisome | 6 | 1 |
GO:0042579 | microbody | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HWN3
Term | Name | Level | Count |
---|---|---|---|
GO:0006084 | acetyl-CoA metabolic process | 5 | 10 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 10 |
GO:0006163 | purine nucleotide metabolic process | 5 | 10 |
GO:0006629 | lipid metabolic process | 3 | 10 |
GO:0006637 | acyl-CoA metabolic process | 4 | 10 |
GO:0006644 | phospholipid metabolic process | 4 | 10 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 10 |
GO:0006753 | nucleoside phosphate metabolic process | 4 | 10 |
GO:0006790 | sulfur compound metabolic process | 3 | 10 |
GO:0006793 | phosphorus metabolic process | 3 | 11 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 10 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0008610 | lipid biosynthetic process | 4 | 10 |
GO:0008654 | phospholipid biosynthetic process | 5 | 10 |
GO:0009058 | biosynthetic process | 2 | 10 |
GO:0009117 | nucleotide metabolic process | 5 | 10 |
GO:0009150 | purine ribonucleotide metabolic process | 6 | 10 |
GO:0009240 | isopentenyl diphosphate biosynthetic process | 6 | 10 |
GO:0009259 | ribonucleotide metabolic process | 5 | 10 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016310 | phosphorylation | 5 | 11 |
GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway | 6 | 10 |
GO:0019637 | organophosphate metabolic process | 3 | 10 |
GO:0019693 | ribose phosphate metabolic process | 4 | 10 |
GO:0033865 | nucleoside bisphosphate metabolic process | 5 | 10 |
GO:0033875 | ribonucleoside bisphosphate metabolic process | 6 | 10 |
GO:0034032 | purine nucleoside bisphosphate metabolic process | 5 | 10 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 10 |
GO:0035383 | thioester metabolic process | 3 | 10 |
GO:0043603 | amide metabolic process | 3 | 10 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 10 |
GO:0044255 | cellular lipid metabolic process | 3 | 10 |
GO:0044281 | small molecule metabolic process | 2 | 10 |
GO:0046483 | heterocycle metabolic process | 3 | 10 |
GO:0046490 | isopentenyl diphosphate metabolic process | 5 | 10 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3 | 10 |
GO:0071704 | organic substance metabolic process | 2 | 10 |
GO:0072521 | purine-containing compound metabolic process | 4 | 10 |
GO:0090407 | organophosphate biosynthetic process | 4 | 10 |
GO:1901135 | carbohydrate derivative metabolic process | 3 | 10 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 10 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 10 |
GO:1901576 | organic substance biosynthetic process | 3 | 10 |
GO:0006720 | isoprenoid metabolic process | 4 | 1 |
GO:0006721 | terpenoid metabolic process | 5 | 1 |
GO:0008299 | isoprenoid biosynthetic process | 4 | 1 |
GO:0010142 | farnesyl diphosphate biosynthetic process, mevalonate pathway | 6 | 1 |
GO:0016114 | terpenoid biosynthetic process | 5 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0045337 | farnesyl diphosphate biosynthetic process | 6 | 1 |
GO:0045338 | farnesyl diphosphate metabolic process | 5 | 1 |
GO:1902767 | isoprenoid biosynthetic process via mevalonate | 5 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 11 |
GO:0003824 | catalytic activity | 1 | 11 |
GO:0004631 | phosphomevalonate kinase activity | 5 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0005524 | ATP binding | 5 | 11 |
GO:0016301 | kinase activity | 4 | 11 |
GO:0016740 | transferase activity | 2 | 11 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 11 |
GO:0016776 | phosphotransferase activity, phosphate group as acceptor | 4 | 11 |
GO:0017076 | purine nucleotide binding | 4 | 11 |
GO:0030554 | adenyl nucleotide binding | 5 | 11 |
GO:0032553 | ribonucleotide binding | 3 | 11 |
GO:0032555 | purine ribonucleotide binding | 4 | 11 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 11 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 11 |
GO:0036094 | small molecule binding | 2 | 11 |
GO:0043167 | ion binding | 2 | 11 |
GO:0043168 | anion binding | 3 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:0097367 | carbohydrate derivative binding | 2 | 11 |
GO:1901265 | nucleoside phosphate binding | 3 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 108 | 112 | PF00656 | 0.476 |
CLV_C14_Caspase3-7 | 298 | 302 | PF00656 | 0.425 |
CLV_NRD_NRD_1 | 221 | 223 | PF00675 | 0.346 |
CLV_NRD_NRD_1 | 247 | 249 | PF00675 | 0.390 |
CLV_NRD_NRD_1 | 293 | 295 | PF00675 | 0.377 |
CLV_NRD_NRD_1 | 308 | 310 | PF00675 | 0.380 |
CLV_NRD_NRD_1 | 319 | 321 | PF00675 | 0.487 |
CLV_PCSK_KEX2_1 | 221 | 223 | PF00082 | 0.310 |
CLV_PCSK_KEX2_1 | 247 | 249 | PF00082 | 0.479 |
CLV_PCSK_KEX2_1 | 293 | 295 | PF00082 | 0.431 |
CLV_PCSK_KEX2_1 | 308 | 310 | PF00082 | 0.415 |
CLV_PCSK_KEX2_1 | 319 | 321 | PF00082 | 0.474 |
CLV_PCSK_SKI1_1 | 269 | 273 | PF00082 | 0.369 |
CLV_PCSK_SKI1_1 | 369 | 373 | PF00082 | 0.288 |
CLV_PCSK_SKI1_1 | 39 | 43 | PF00082 | 0.381 |
DEG_APCC_DBOX_1 | 368 | 376 | PF00400 | 0.432 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.451 |
DEG_SPOP_SBC_1 | 166 | 170 | PF00917 | 0.445 |
DEG_SPOP_SBC_1 | 43 | 47 | PF00917 | 0.375 |
DOC_CDC14_PxL_1 | 339 | 347 | PF14671 | 0.400 |
DOC_CYCLIN_RxL_1 | 363 | 374 | PF00134 | 0.497 |
DOC_CYCLIN_RxL_1 | 5 | 14 | PF00134 | 0.309 |
DOC_MAPK_DCC_7 | 144 | 152 | PF00069 | 0.487 |
DOC_MAPK_DCC_7 | 437 | 445 | PF00069 | 0.329 |
DOC_MAPK_MEF2A_6 | 144 | 152 | PF00069 | 0.487 |
DOC_MAPK_MEF2A_6 | 263 | 272 | PF00069 | 0.380 |
DOC_PP1_RVXF_1 | 286 | 293 | PF00149 | 0.305 |
DOC_PP4_FxxP_1 | 262 | 265 | PF00568 | 0.343 |
DOC_USP7_MATH_1 | 102 | 106 | PF00917 | 0.418 |
DOC_USP7_MATH_1 | 365 | 369 | PF00917 | 0.483 |
DOC_USP7_MATH_1 | 48 | 52 | PF00917 | 0.440 |
DOC_USP7_MATH_1 | 71 | 75 | PF00917 | 0.442 |
DOC_WW_Pin1_4 | 19 | 24 | PF00397 | 0.482 |
DOC_WW_Pin1_4 | 279 | 284 | PF00397 | 0.423 |
DOC_WW_Pin1_4 | 296 | 301 | PF00397 | 0.390 |
DOC_WW_Pin1_4 | 57 | 62 | PF00397 | 0.390 |
DOC_WW_Pin1_4 | 86 | 91 | PF00397 | 0.376 |
LIG_14-3-3_CanoR_1 | 227 | 231 | PF00244 | 0.445 |
LIG_14-3-3_CanoR_1 | 293 | 297 | PF00244 | 0.391 |
LIG_14-3-3_CanoR_1 | 35 | 41 | PF00244 | 0.414 |
LIG_14-3-3_CanoR_1 | 64 | 68 | PF00244 | 0.511 |
LIG_APCC_ABBA_1 | 428 | 433 | PF00400 | 0.352 |
LIG_BRCT_BRCA1_1 | 59 | 63 | PF00533 | 0.333 |
LIG_BRCT_BRCA1_1 | 65 | 69 | PF00533 | 0.332 |
LIG_CSL_BTD_1 | 255 | 258 | PF09270 | 0.492 |
LIG_CtBP_PxDLS_1 | 385 | 389 | PF00389 | 0.513 |
LIG_deltaCOP1_diTrp_1 | 254 | 262 | PF00928 | 0.389 |
LIG_EVH1_2 | 258 | 262 | PF00568 | 0.393 |
LIG_FHA_1 | 166 | 172 | PF00498 | 0.445 |
LIG_FHA_1 | 35 | 41 | PF00498 | 0.345 |
LIG_FHA_1 | 387 | 393 | PF00498 | 0.439 |
LIG_FHA_2 | 108 | 114 | PF00498 | 0.397 |
LIG_LIR_Apic_2 | 254 | 259 | PF02991 | 0.460 |
LIG_LIR_Apic_2 | 260 | 265 | PF02991 | 0.413 |
LIG_LIR_Gen_1 | 113 | 120 | PF02991 | 0.441 |
LIG_LIR_Gen_1 | 14 | 23 | PF02991 | 0.361 |
LIG_LIR_Gen_1 | 209 | 219 | PF02991 | 0.492 |
LIG_LIR_Gen_1 | 413 | 420 | PF02991 | 0.432 |
LIG_LIR_Gen_1 | 433 | 443 | PF02991 | 0.382 |
LIG_LIR_Gen_1 | 66 | 75 | PF02991 | 0.367 |
LIG_LIR_Nem_3 | 113 | 118 | PF02991 | 0.417 |
LIG_LIR_Nem_3 | 14 | 18 | PF02991 | 0.323 |
LIG_LIR_Nem_3 | 206 | 211 | PF02991 | 0.432 |
LIG_LIR_Nem_3 | 217 | 223 | PF02991 | 0.295 |
LIG_LIR_Nem_3 | 301 | 307 | PF02991 | 0.343 |
LIG_LIR_Nem_3 | 413 | 419 | PF02991 | 0.432 |
LIG_LIR_Nem_3 | 429 | 435 | PF02991 | 0.314 |
LIG_LIR_Nem_3 | 66 | 70 | PF02991 | 0.368 |
LIG_NRBOX | 387 | 393 | PF00104 | 0.445 |
LIG_Pex14_2 | 63 | 67 | PF04695 | 0.377 |
LIG_RPA_C_Fungi | 358 | 370 | PF08784 | 0.331 |
LIG_SH2_CRK | 211 | 215 | PF00017 | 0.399 |
LIG_SH2_CRK | 412 | 416 | PF00017 | 0.304 |
LIG_SH2_NCK_1 | 211 | 215 | PF00017 | 0.399 |
LIG_SH2_NCK_1 | 412 | 416 | PF00017 | 0.304 |
LIG_SH2_NCK_1 | 98 | 102 | PF00017 | 0.298 |
LIG_SH2_SRC | 130 | 133 | PF00017 | 0.396 |
LIG_SH2_SRC | 15 | 18 | PF00017 | 0.344 |
LIG_SH2_STAP1 | 211 | 215 | PF00017 | 0.285 |
LIG_SH2_STAP1 | 332 | 336 | PF00017 | 0.392 |
LIG_SH2_STAP1 | 412 | 416 | PF00017 | 0.285 |
LIG_SH2_STAP1 | 98 | 102 | PF00017 | 0.357 |
LIG_SH2_STAT5 | 130 | 133 | PF00017 | 0.353 |
LIG_SH2_STAT5 | 15 | 18 | PF00017 | 0.320 |
LIG_SH2_STAT5 | 188 | 191 | PF00017 | 0.331 |
LIG_SH2_STAT5 | 211 | 214 | PF00017 | 0.285 |
LIG_SH2_STAT5 | 314 | 317 | PF00017 | 0.313 |
LIG_SH2_STAT5 | 435 | 438 | PF00017 | 0.478 |
LIG_SH3_2 | 258 | 263 | PF14604 | 0.446 |
LIG_SH3_3 | 145 | 151 | PF00018 | 0.432 |
LIG_SH3_3 | 252 | 258 | PF00018 | 0.468 |
LIG_SH3_3 | 340 | 346 | PF00018 | 0.398 |
LIG_SH3_3 | 401 | 407 | PF00018 | 0.266 |
LIG_SH3_3 | 451 | 457 | PF00018 | 0.514 |
LIG_SUMO_SIM_par_1 | 384 | 390 | PF11976 | 0.424 |
LIG_SUMO_SIM_par_1 | 441 | 448 | PF11976 | 0.332 |
LIG_SUMO_SIM_par_1 | 8 | 14 | PF11976 | 0.312 |
LIG_TRFH_1 | 262 | 266 | PF08558 | 0.464 |
MOD_CDK_SPxxK_3 | 57 | 64 | PF00069 | 0.437 |
MOD_CK1_1 | 105 | 111 | PF00069 | 0.507 |
MOD_CK1_1 | 226 | 232 | PF00069 | 0.499 |
MOD_CK1_1 | 51 | 57 | PF00069 | 0.547 |
MOD_CK2_1 | 107 | 113 | PF00069 | 0.409 |
MOD_CK2_1 | 236 | 242 | PF00069 | 0.490 |
MOD_GlcNHglycan | 163 | 166 | PF01048 | 0.266 |
MOD_GlcNHglycan | 2 | 6 | PF01048 | 0.319 |
MOD_GlcNHglycan | 205 | 208 | PF01048 | 0.266 |
MOD_GlcNHglycan | 233 | 236 | PF01048 | 0.634 |
MOD_GlcNHglycan | 447 | 452 | PF01048 | 0.473 |
MOD_GlcNHglycan | 50 | 53 | PF01048 | 0.640 |
MOD_GlcNHglycan | 72 | 76 | PF01048 | 0.493 |
MOD_GlcNHglycan | 85 | 89 | PF01048 | 0.374 |
MOD_GSK3_1 | 102 | 109 | PF00069 | 0.383 |
MOD_GSK3_1 | 156 | 163 | PF00069 | 0.266 |
MOD_GSK3_1 | 292 | 299 | PF00069 | 0.435 |
MOD_GSK3_1 | 44 | 51 | PF00069 | 0.639 |
MOD_N-GLC_2 | 439 | 441 | PF02516 | 0.349 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.435 |
MOD_NEK2_1 | 161 | 166 | PF00069 | 0.302 |
MOD_NEK2_1 | 167 | 172 | PF00069 | 0.329 |
MOD_NEK2_1 | 231 | 236 | PF00069 | 0.484 |
MOD_NEK2_1 | 392 | 397 | PF00069 | 0.266 |
MOD_NEK2_1 | 63 | 68 | PF00069 | 0.403 |
MOD_NEK2_2 | 52 | 57 | PF00069 | 0.488 |
MOD_PIKK_1 | 123 | 129 | PF00454 | 0.317 |
MOD_PIKK_1 | 130 | 136 | PF00454 | 0.366 |
MOD_PIKK_1 | 197 | 203 | PF00454 | 0.383 |
MOD_PKA_2 | 226 | 232 | PF00069 | 0.478 |
MOD_PKA_2 | 292 | 298 | PF00069 | 0.391 |
MOD_PKA_2 | 34 | 40 | PF00069 | 0.399 |
MOD_PKA_2 | 63 | 69 | PF00069 | 0.346 |
MOD_Plk_4 | 11 | 17 | PF00069 | 0.314 |
MOD_Plk_4 | 167 | 173 | PF00069 | 0.285 |
MOD_Plk_4 | 226 | 232 | PF00069 | 0.505 |
MOD_ProDKin_1 | 19 | 25 | PF00069 | 0.471 |
MOD_ProDKin_1 | 279 | 285 | PF00069 | 0.414 |
MOD_ProDKin_1 | 296 | 302 | PF00069 | 0.384 |
MOD_ProDKin_1 | 57 | 63 | PF00069 | 0.394 |
MOD_ProDKin_1 | 86 | 92 | PF00069 | 0.368 |
MOD_SUMO_for_1 | 381 | 384 | PF00179 | 0.399 |
MOD_SUMO_for_1 | 41 | 44 | PF00179 | 0.497 |
MOD_SUMO_rev_2 | 374 | 383 | PF00179 | 0.399 |
TRG_DiLeu_BaEn_1 | 387 | 392 | PF01217 | 0.345 |
TRG_DiLeu_BaLyEn_6 | 439 | 444 | PF01217 | 0.337 |
TRG_ENDOCYTIC_2 | 15 | 18 | PF00928 | 0.320 |
TRG_ENDOCYTIC_2 | 211 | 214 | PF00928 | 0.345 |
TRG_ENDOCYTIC_2 | 220 | 223 | PF00928 | 0.229 |
TRG_ENDOCYTIC_2 | 412 | 415 | PF00928 | 0.285 |
TRG_ENDOCYTIC_2 | 435 | 438 | PF00928 | 0.336 |
TRG_ER_diArg_1 | 220 | 222 | PF00400 | 0.305 |
TRG_ER_diArg_1 | 246 | 248 | PF00400 | 0.389 |
TRG_ER_diArg_1 | 292 | 294 | PF00400 | 0.411 |
TRG_ER_diArg_1 | 307 | 309 | PF00400 | 0.416 |
TRG_ER_diArg_1 | 318 | 320 | PF00400 | 0.444 |
TRG_Pf-PMV_PEXEL_1 | 320 | 324 | PF00026 | 0.542 |
TRG_Pf-PMV_PEXEL_1 | 369 | 374 | PF00026 | 0.269 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P784 | Leptomonas seymouri | 76% | 100% |
A0A0S4JMH3 | Bodo saltans | 55% | 100% |
A0A1D8PLH0 | Candida albicans (strain SC5314 / ATCC MYA-2876) | 29% | 100% |
A0A1X0NVR4 | Trypanosomatidae | 56% | 100% |
A0A3S5IQX7 | Trypanosoma rangeli | 55% | 98% |
A0A3S7WTM8 | Leishmania donovani | 100% | 100% |
A4H8B3 | Leishmania braziliensis | 84% | 100% |
C9ZXQ3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 51% | 97% |
E9AQE1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
I1RZD0 | Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) | 31% | 100% |
P24521 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 30% | 100% |
Q4QF34 | Leishmania major | 95% | 100% |
Q4WV38 | Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) | 29% | 95% |
Q9C6T1 | Arabidopsis thaliana | 34% | 91% |
Q9UT88 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 29% | 100% |